Abstract: A machine for extracorporeal blood treatment includes a user interface having a touch screen and a controller programmed to display on a screen (16) a display in which two distinct areas are arranged, one of which (161) exhibits a series of touch keys (17), wherein activation of any one touch key (17) causes visualization of an image in a second area (162) of the screen, wherein the images are displayed alternatively and are at least partly different one from another, wherein each touch key (17) is associated to an instruction, or to a group of instructions, each concerned with readying the machine for use, wherein each image is a pictograph of a configuration of the machine, correlated with an instruction associated to the touch key (17) selected, and wherein the operator is aided in making the machine ready for treatment.

Abstract: Polymer/carbon nanotube composites made up of melamine, aldehyde, diaminoalkane monomeric units and carbon nanotubes having activated carbonyl groups. A method for removing heavy metals, such as Pb(II) from an aqueous solution or an industrial wastewater sample with these composites is introduced. A process of synthesizing the polymer/carbon nanotube composites is also described.

Abstract: Absolute blood volume in dialysis patients is a useful patient attribute to know for dialysis treatment, diagnosis, adjustments, etc. In some cases, it is difficult or impossible to directly determine absolute blood volume. Estimating absolute blood volume may be used to overcome the inability to directly determine the absolute blood volume. Estimating absolute blood volume may include obtaining a series of measurements of hemoconcentration of a patient over a time period, and estimating parameters for a physiological model based on the series of measurements. The absolute blood volume of the patient may be determined using the physiological model.

Abstract: Described herein is a polyamide hollow fiber membrane and methods of making and using the hollow fiber membrane. The polyamide hollow fiber membrane has an isopropanol permeability of from about 5 L/m2 h bar to about 150 L/m2 h bar and a particle rejection percentage of about 100% for particles having a nominal diameter of from about 1 nm to about 25 nm. The polyamide hollow fiber membranes described herein are particularly useful for photoresist filtration, for example.

Abstract: A polyethylene resin composition comprising from 50 to 89 parts by weight of a linear low density polyethylene (A) having specific physical properties, from 10 to 40 parts by weight of a high density polyethylene (B) having specific physical properties, and from 1 to 20 parts by weight of a high pressure low density polyethylene (C) having specific physical properties (the total amount of (A), (B) and (C) is 100 parts by weight), and having MFR of from 3.0 to 9.0 g/10 min, is excellent in heat resistance, flexibility, barrier property and cleanness (low particle property), will not deform even after sterilization at 121° C., maintains high transparency and is excellent in processability in water cooling blown-film extrusion, and a medical container using it.

Abstract: A nanobiocatalytic membrane for a filtration system is provided which includes a filtration membrane and a plurality of nanobiocatalyst nanoparticles associated with the membrane, each of the nanobiocatalyst nanoparticles including a core, a coating at least partially surrounding the core, and a plurality of nanobiocatalysts coupled to the coating. Each of the plurality of nanobiocatalysts includes an antibacterial nanoparticle comprising bismuth, and a quorum quenching agent coupled to the antibacterial nanoparticle. A nanobiocatalyst nanoparticle for use with a water purification system is also provided. A method of forming a nanobiocatalytic membrane for a filtration system and a method of using a nanobiocatalytic membrane in a filtration system are also provided.

Abstract: A hand-held microfluidic testing device is provided that includes a housing having a cartridge receiving port, a cartridge for input to the cartridge receiving port having a sample input and a channel, where the channel includes a mixture of Raman-scattering nanoparticles and a calibration solution, where the calibration solution includes chemical compounds capable of interacting with a sample under test input to the cartridge and the Raman-scattering nanoparticles, and an optical detection system in the housing, where the optical detection system is capable of providing an illuminated electric field, where the illuminating electric field is capable of being used for Raman spectroscopy with the Raman-scattering nanoparticles and the calibration solution to analyze the sample under test input to the cartridge.

Abstract: Embodiments of the present disclosure provide for systems for removing contaminants from a leachate, methods of removing contaminants from a leachate, and the like.

Abstract: The invention regards a device for reconstituting a bioactive agent and forming a flowable paste, the device comprising: —a base configured for receiving: —a first container containing a liquid, and —a second container containing the bioactive agent, —a syringe containing a paste forming material, the syringe being attachable to the base, wherein the base has a first conduit for fluidly connecting the first container with the second container and a second conduit for fluidly connecting the second container with the syringe, and wherein the first container is configured to be pressurizable such that when the first and second containers are received at the base, the liquid is forced through the first conduit into the second container, thereby reconstituting the bioactive agent, and the reconstituted bioactive agent is forced through the second conduit into the syringe, such that a paste is formed.

Abstract: A blood based solute monitoring system for measuring at least one blood solute species that has a first recirculation flow path in communication with a dialyzer. The first recirculation flow path is configured to allow a fluid to recirculate through a dialyzer such that the concentration of at least one solute species in the fluid becomes equilibrated to the solute species concentration of the blood compartment of the dialyzer. The blood solute monitoring system has at least one sensor to measure a fluid characteristic.

Abstract: A method for setting a control device or a closed-loop control device of a blood treatment apparatus, includes providing, determining or reading out a correction factor and correcting the flow value and/or the treatment target entered by the user by or about the correction factor. Furthermore, the present disclosure relates to a blood treatment apparatus, a digital storage medium, a computer program product, and a computer program.

Abstract: A dialysis system is provided that includes a dialysis machine and a potassium sensing device that is configured to measure the concentration of potassium in the patient's blood, in spent dialysate resulting from treating the patient, or in both. The potassium sensing device can be configured to generate a sensed value of the concentration of potassium. A control and computing unit, including a processor and a memory, is configured to receive the sensed value, compare the value with one or more values stored in the memory, and generate a control signal based on the comparison. A potassium infusion circuit uses the control signal to infuse supplemental potassium solution into the treatment dialysate, a replacement fluid, or both. The memory can include stored patient-historical and population data.

Abstract: The present invention concerns a filtration membrane bundle (30) comprising a plurality of elongated filtration fibers (40) arranged in a spiraled coil (34); and one or more filaments (50) woven around the plurality of elongated filtration fibers (40) binding one or more adjacent elongated filtration fibers (40) at a predetermined and homogeneous spacing (44,48) from one another wherein each elongated filtration fiber (40) is bound to respective adjacent elongated filtration fibers (40) in a co-planar configuration, and wherein the co-planar configuration of filtration fibers (40) are rolled into a coil (34). Furthermore, a filtration membrane assembly comprising the filtration membrane bundle (30) and a housing and method of providing the filtration membrane bundle (30) are disclosed.

Abstract: Red blood cell products and compositions are disclosed. The product includes a container made from PVC or a non-PVC material that is substantially free of a phthalate plasticizer but otherwise includes one or more non-phthalate plasticizers or extractable agents. The product includes a RBC concentrate which has been combined with an additive solution for storing the RBCs.

Abstract: Disclosed is a polymer for capturing or separating leukocytes. The polymer is prepared by a polymerization reaction of monomers containing an amino and a hydroxyl. The monomer containing an amino and a hydroxyl has the structure of formula (1): In formula (1), R1 is independently selected from the group consisting of a hydrogen, a methyl, an ethyl, a hydroxyl, any one of C1 to C12 long carbon chains, and a benzene ring, R2 is independently selected from the group consisting of a hydrogen, a methyl, an ethyl, any one of from C1 to C6 long carbon chains, an amino and a benzene ring, and n is an integer of 1 to 5.

Abstract: An extracorporeal blood filtering machine can include a blood circuit, an effluent circuit, and a source fluid circuit and can be controlled by a controller. The extracorporeal blood filtering machine can also include access ports for connecting the source fluid circuit to the blood circuit, as well as blood sensors to detect possible issues with the extracorporeal blood filtering machine. The extracorporeal blood filtering machine can include density sensors and flow sensors that enable it to be more accurate and to operate while being transported. The extracorporeal blood filtering machine can further include a user interface and can display fluid inflow/outflow information. A medical fluid container can automatically empty after being filled. An apparatus for supporting a medical fluid container can include a hanger and an attachment member with the apparatus able to adjust to ensure the medical fluid container remains properly oriented directly under a medical fluid container scale.

Abstract: A substrate for use in a filter media including, for example, in a hydrocarbon fluid-water separation filter; methods of identifying the substrate; methods of making the substrate; methods of using the substrate; and methods of improving the roll off angle of the substrate. In some embodiments, the substrate includes a hydrophilic group-containing polymer or a hydrophilic group-containing polymer coating.

Abstract: The invention provides systems and methods for substantially improving the compaction resistance of isoporous block copolymer (BCP) film by adding a high molecular weight hydrophilic additive in the casting dope formulation. Systems and methods disclosed also disclose several other multifunctional enhancements to film properties including: low fouling propensity, improved permeability, improved permeability retention upon drying, and ability to tune the substructure and pore size of these novel BCP films. These porous BCP films are useful in filtration and separations applications and are amenable to standard manufacturing practices.

Abstract: The present invention discloses a sterile PRP separation kit that has compartmentalized container having a cover that allows for a stage-specific exposure of sterile components of the sterile PRP separation kit housed within stage-specific compartments to a non-sterile environment commensurate with a specific stage of operation of a separation process of PRP. The sterile PRP separation kit includes a PRP tube with segregated portals for injection of blood into the PRP tube, aspiration of PRP from the PRP tube, and for maintaining an interior pressure of the PRP tube at equilibrium with ambient pressure during both injection and aspiration.

Abstract: A filtration membrane coating comprising a hydrophilic polymer, a surfactant, and one or more charged compounds, each containing one or more sulfonate functionalities and one or more linkable functionalities selected from the group consisting of amine, monochlorotriazine, and dichlorotriazine. The hydrophilic polymer and surfactant form a thin primer layer which is also superhydrophilic. The primer layer improves flux, and enables improved adhesion of the one or more charged compounds, which form a charged dye layer on top of the primer layer when enhances rejection of charged divalent ions. The coating can be applied while the membrane is packaged in its final form, such as in a spiral wound or other configuration.